 BioDelivery Sciences International Inc NASDAQ: BDSI has reported Q2 sales of 41.4 million, 13.3 YY, missing the consensus of 42.4 million. Sales growth was driven by all-time high Belbuca sales of 36.5 million, 13 YY, and Symproic sales of 4 million, up 18 YY. 